Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
6
×
Tags
boston blog main
6
×
life sciences
national blog main
biotech
boston top stories
clinical trials
boston
medical device
new york blog main
san francisco blog main
cancer
cancer diagnostics
deals
drug delivery
fda
freenome
grail
investing
liquid biopsy
national top stories
raleigh-durham blog main
san francisco top stories
startups
thrive earlier detection
480 biomedical
abbvie
actavalon
acute myeloid leukemia
aileron therapeutics
alnylam pharmaceuticals
amgen
aprea therapeutics
arimoclomol
arnold levine
arrowmark partners
arsenal medical
baker brothers
beta bionics
bigfoot biomedical
biotech ipos
What
tests
6
×
developing
blood
company
ipo
million
based
cancer
medicines
new
public
announced
area
bay
begin
beta
bionics
biopsy
biosciences
biotech
bio’s
bringing
brings
broader
bubbles
buildout
cells
cholesterol
class
clears
clinical
close
closed
closer
codiak
debut
detect
device
diabetes
driven
Language
unset
Current search:
tests
×
photo
×
" boston blog main "
×
@xconomy.com
3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@xconomy.com
3 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow
@xconomy.com
4 years ago
MedCo Preps for FDA Filing as Cholesterol Drug Clears Last Two Tests
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests